New gel treatment for Parkinson's aims to reduce 'Off' time

NCT ID NCT07313176

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study follows about 215 adults with advanced Parkinson's disease who are switching from a pump medication to a new intestinal gel called LECIGON®. Researchers want to see if the gel reduces daily 'off' time—when symptoms return—over 12 months. Participants continue their usual care while doctors track changes using a standard rating scale.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED PARKINSON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

movement disorder neurodegenerative disease Parkinson disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Complejo Hospitalario Universitario de A Coruña (CHUAC)

    RECRUITING

    A Coruña, A Coruña, 15006, Spain

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Hospital Universitario de Toledo

    RECRUITING

    Toledo, Castille-La Mancha, 45007, Spain

  • Hospital de Basurto

    RECRUITING

    Bilbao, Vizcaya, 48013, Spain

  • Hospital de Cruces

    RECRUITING

    Barakaldo, Vizcaya, 48903, Spain

  • Virgen del Rocío University Hospital

    RECRUITING

    Seville, Av. Manuel Siurot, S/n, 41013, Spain

    Contact